
GC62461
FNDR-20123
Also known as N-hydroxy-4-[[4-[4-(pyrrolidin-1-ylmethyl)phenyl]triazol-1-yl]methyl]benzamide;hydrochloride
FNDR-20123 is a safe, first-in-class, and orally active anti-malarial HDAC inhibitor with IC50s of 31 nM and 3 nM for Plasmodium and human HDAC, respectively
ChemicalCAS2641930-61-0MW413.9FormulaC21H24ClN5O2
- CAS number
- 2641930-61-0
- Molecular weight
- 413.9
- Formula
- C21H24ClN5O2
- Solubility
- DMSO : 31·25 mg/mL (75·50 mM; Need ultrasonic)
- InChIKey
- UAJSGJVDCCRISR-UHFFFAOYSA-N
- Catalogue number
- GC62461
- Brand
- GLPBIO
Computed properties PubChem CID 155981967 · TPSA 83.3 Ų · H-bond donors 3 · H-bond acceptors 5
- TPSA
- 83.3 Ų
- H-bond donors
- 3
- H-bond acceptors
- 5
- Rotatable bonds
- 6
- Heavy atoms
- 29
SMILES C1CCN(C1)CC2=CC=C(C=C2)C3=CN(N=N3)CC4=CC=C(C=C4)C(=O)NO.Cl
Computed descriptors from PubChem (CID 155981967), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il